tiprankstipranks
Trending News
More News >
Regen Biopharma (RGBP)
OTHER OTC:RGBP
US Market
Advertisement

Regen Biopharma (RGBP) Technical Analysis

Compare
123 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
3Neutral
13Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Regen Biopharma’s (RGBP) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Regen Biopharma is a Buy.
Regen Biopharma’s (RGBP) 20-Day exponential moving average is 0.03, while Regen Biopharma’s (RGBP) share price is <$0.1, making it a Sell.
Regen Biopharma’s (RGBP) 50-Day exponential moving average is 0.04, while Regen Biopharma’s (RGBP) share price is <$0.1, making it a Sell.

Regen Biopharma (RGBP) Pivot Points

Sep 05, 2025, 02:13 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
<0.01
0.01
0.02
0.02
0.03
0.03
0.03
Fibonacci
0.01
0.02
0.02
0.02
0.02
0.03
0.03
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Regen Biopharma (RGBP) Moving Averages

Sep 05, 2025, 02:13 PM
Period
Simple
Exponential
MA5
0.02Buy
0.02Sell
MA10
0.02Sell
0.02Sell
MA20
0.03Sell
0.03Sell
MA50
0.05Sell
0.04Sell
MA100
0.05Sell
0.05Sell
MA200
0.06Sell
0.07Sell
Regen Biopharma’s (RGBP) 10-Day exponential moving average is 0.02, while Regen Biopharma’s (RGBP) share price is <$0.1, making it a Sell.
Regen Biopharma’s (RGBP) 100-Day exponential moving average is 0.05, while Regen Biopharma’s (RGBP) share price is <$0.1, making it a Sell.
Regen Biopharma’s (RGBP) stock price is <$0.1 and Regen Biopharma’s (RGBP) 50-day simple moving average is 0.05, creating a Sell signal.
Regen Biopharma’s (RGBP) stock price is <$0.1 and Regen Biopharma’s (RGBP) 100-day simple moving average is 0.05, creating a Sell signal.
Regen Biopharma’s (RGBP) stock price is <$0.1 and Regen Biopharma’s (RGBP) 200-day simple moving average is 0.06, creating a Sell signal.

Regen Biopharma (RGBP) Technical Indicators

Sep 05, 2025, 02:13 PM
Name
Value
Implied Action
RSI (14)
32.24
Neutral
STOCH (9,6)
28.48
Neutral
STOCHRSI (14)
16.95
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
18.14
Buy
Williams %R
-72.97
Buy
CCI (14)
-114.52
Buy
ATR (14)
0.01
-
Ultimate Oscillator
36.83
Neutral
ROC
-66.67
Sell
Regen Biopharma’s (RGBP) Relative Strength Index (RSI) is 32.24, creating a Neutral signal.
Regen Biopharma’s (RGBP) Trend Strength Indicator (ADX) is 18.14, creating a Buy signal.
Regen Biopharma’s (RGBP) Commodity Channel Index (CCI) is -114.52, creating a Buy signal.
Regen Biopharma’s (RGBP) Price Rate of Change (ROC) is -66.67, creating a Sell signal.

FAQ

Is RGBP a Buy, Hold, or Sell?
Based on RGBP’s technical indicators, RGBP is a Sell.
    What is RGBP’s RSI (14)?
    RGBP’s RSI (14) is 32.24, which suggests RGBP is a Neutral.
      What is RGBP’s MACD?
      RGBP’s MACD is >-0.01, which suggests RGBP is a Buy.
        What is RGBP’s 5-day moving average?
        RGBP’s 5-day moving average is 0.02, which suggests RGBP is a Buy.
          What is RGBP’s 20-day moving average?
          RGBP 20-day moving average is 0.03, which suggests RGBP is a Sell.
            What is RGBP’s 50-day moving average?
            RGBP’s 50-day moving average is 0.05, which suggests RGBP is a Sell.
              What is RGBP’s 200-day moving average?
              RGBP’s 200-day moving average is 0.06, which suggests RGBP is a Sell.
                What is RGBP’s Williams % R (14)?
                RGBP’s Williams % R (14) is -72.97, which suggests RGBP is a Buy.
                  What is RGBP’s CCI (14)?
                  RGBP’s CCI (14) is -114.52, which suggests RGBP is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis